JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5701
Forafric Global
AFRI
$297M
| $59.2K | ﹤0.01% |
5,586
+2,200
| +65% | +$24.3K |
2023 Q2
2 quarters
|
|
|
ASXC
5702
DELISTED
Asensus Surgical, Inc.
ASXC
| $58.9K | ﹤0.01% |
184,714
-9,148
| -5% | -$2.36K |
2023 Q1
3 quarters
|
|
5703
Greenwich LifeSciences
GLSI
$255M
| $58.7K | ﹤0.01% |
5,578
+5,574
| +139,350% | +$55.9K |
2021 Q2
10 quarters
|
|
|
DNMR
5704
DELISTED
Danimer Scientific, Inc.
DNMR
| $58.6K | ﹤0.01% |
1,437
| – | – |
2021 Q1
11 quarters
|
|
5705
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$216M
| $58K | ﹤0.01% |
1,773
+116
| +7% | +$4.05K |
2022 Q3
5 quarters
|
|
|
GPGI
5706
GPGI Inc
GPGI
$3.49B
| $57.6K | ﹤0.01% |
12,832
| – | – |
2022 Q1
7 quarters
|
|
|
SEVN
5707
Seven Hills Realty Trust
SEVN
$154M
| $57.4K | ﹤0.01% |
+4,438
| New | +$50.1K |
2023 Q4
0 quarters
|
|
5708
PUT
Arcus Biosciences
RCUS
$3.21B
| $57.3K | ﹤0.01% |
3,000
-30,200
| -91% | -$483K |
2023 Q2
2 quarters
|
|
|
MCR
5709
DELISTED
MFS Charter Income Trust
MCR
| $57.2K | ﹤0.01% |
8,855
+6,068
| +218% | +$36.6K |
2022 Q4
4 quarters
|
|
5710
Zura Bio
ZURA
$399M
| $57.1K | ﹤0.01% |
12,230
+4,411
| +56% | +$22.1K |
2023 Q2
2 quarters
|
|
|
DZSI
5711
DELISTED
DZS Inc. Common Stock
DZSI
| $57K | ﹤0.01% |
28,920
+14,321
| +98% | +$22.4K |
2016 Q4
28 quarters
|
|
|
THRX
5712
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $56.9K | ﹤0.01% |
14,052
+911
| +7% | +$2.78K |
2021 Q4
8 quarters
|
|
5713
ProShares UltraPro Short Russell2000
SRTY
$73.8M
| $56.5K | ﹤0.01% |
468
-688
| -60% | -$126K |
2023 Q3
1 quarter
|
|
|
AXIA
5714
DELISTED
AXIA Energia
AXIA
| $56.2K | ﹤0.01% |
8,237
+66
| +0.8% | +$405 |
2016 Q4
28 quarters
|
|
5715
KORU Medical Systems
KRMD
$139M
| $55.6K | ﹤0.01% |
22,658
| – | – |
2023 Q1
3 quarters
|
|
5716
Urban One Class D
UONEK
$16.8M
| $55.5K | ﹤0.01% |
1,571
+757
| +93% | +$34.6K |
2022 Q2
6 quarters
|
|
5717
Vor Biopharma
VOR
$1.07B
| $55.1K | ﹤0.01% |
1,225
-40
| -3% | -$1.65K |
2021 Q1
11 quarters
|
|
|
VBNK
5718
VersaBank
VBNK
$717M
| $55.1K | ﹤0.01% |
5,029
-1,384
| -22% | -$11.3K |
2021 Q3
9 quarters
|
|
|
TGB
5719
Trekor Metals
TGB
$3.04B
| $55.1K | ﹤0.01% |
39,328
-27,349
| -41% | -$33.6K |
2017 Q1
27 quarters
|
|
5720
Wheels Up
UP
$121M
| $55K | ﹤0.01% |
+802
| New | +$31K |
2023 Q4
0 quarters
|
|
5721
INNOVATE Corp
VATE
$101M
| $54.8K | ﹤0.01% |
4,459
+862
| +24% | +$10.6K |
2016 Q2
30 quarters
|
|
|
CET
5722
Central Securities Corp
CET
$1.64B
| $54.6K | ﹤0.01% |
+1,446
| New | +$52.6K |
2023 Q4
0 quarters
|
|
5723
Evogene
EVGN
$6.88M
| $54.3K | ﹤0.01% |
6,459
+2,933
| +83% | +$18.4K |
2023 Q3
1 quarter
|
|
|
RSVRW
5724
DELISTED
Reservoir Media Inc Warrant
RSVRW
| – | – |
0
| – | – |
2021 Q4
8 quarters
|
|
5725
Zevia
ZVIA
$87.3M
| $53.7K | ﹤0.01% |
26,740
+10,575
| +65% | +$21.2K |
2023 Q2
2 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.